Position in PFE
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$1,667,082
-$320,813 QoQ
Shares Held
69,231
-2.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.38%
of 13F equity value
Holder Rank
#1,035
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Plancorp, LLC holds $29,476,537 across 10 Drug Manufacturers - General names. PFE ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,332 | $13,591,941 | |
| 2 | ABBV |
AbbVie Inc.
|
16,225 | $4,082,859 | |
| 3 | JNJ |
Johnson & Johnson
|
14,300 | $3,631,771 | |
| 4 | NVS |
Novartis AG
|
12,291 | $1,926,245 | |
| 5 | PFE |
Pfizer Inc
This page
|
69,231 | $1,667,082 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,133 | $1,559,090 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
16,457 | $948,252 | |
| 8 | AMGN |
Amgen Inc
|
2,399 | $868,725 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,667,082 | 69,231 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $1,987,895 | 70,794 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $2,056,117 | 82,575 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $2,592,997 | 101,766 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $2,457,960 | 101,401 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,669,695 | 105,355 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,599,435 | 97,981 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $2,749,676 | 95,013 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,593,718 | 92,699 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,575,200 | 92,800 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,626,828 | 91,241 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $3,076,185 | 92,740 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,341,951 | 91,111 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $6,432,691 | 157,664 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $8,113,649 | 158,346 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,841,657 | 156,345 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,894,820 | 36,140 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,732,431 | 33,464 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $2,013,723 | 34,102 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $1,415,459 | 32,910 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,290,047 | 32,943 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,156,534 | 31,922 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,237,736 | 33,625 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $950,345 | 25,895 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,002,877 | 30,669 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $1,031,553 | 31,604 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||